MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Align Technology Long-Term Debt 2011-2026 | ALGN
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Align Technology
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88.2 M | 97 M | 100 M | 103 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 103 M | 88.2 M | 97 M |
Quarterly Long-Term Debt Align Technology
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.3 M | 90.5 M | 86.5 M | 88.2 M | 96.4 M | 98.3 M | 95.1 M | 97 M | 98.5 M | 105 M | 99 M | 100 M | 96.7 M | - | 105 M | 103 M | 74.4 M | 74.2 M | 63.8 M | 64.4 M | 64.4 M | 64.4 M | 64.4 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 105 M | 43.5 M | 80.4 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
49.1 M | $ 9.23 | -1.6 % | $ 261 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
EDAP TMS S.A.
EDAP
|
2 M | $ 3.46 | - | $ 130 M |  France |
 |
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.72 B | $ 12.07 | - | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
FONAR Corporation
FONR
|
155 K | $ 18.6 | - | $ 122 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
2.06 B | $ 36.66 | -0.22 % | $ 5.46 K | USA |
 |
Globus Medical
GMED
|
436 K | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
12 K | $ 1.81 | -4.74 % | $ 1.1 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
760 M | $ 9.25 | -0.64 % | $ 712 M | USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
Inspire Medical Systems
INSP
|
30 M | $ 54.21 | 0.13 % | $ 1.59 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.19 B | $ 85.77 | 0.16 % | $ 2.98 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 15.78 | -1.0 % | $ 370 M | USA |
 |
IRIDEX Corporation
IRIX
|
98 K | $ 1.01 | 1.85 % | $ 17.1 M | USA |
 |
LENSAR
LNSR
|
1.99 M | $ 5.82 | -1.27 % | $ 69.6 M | USA |
 |
Medtronic PLC
MDT
|
25.6 B | $ 86.12 | -0.19 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
Myomo
MYO
|
11.2 M | $ 0.67 | -4.9 % | $ 28 M | USA |
 |
AxoGen
AXGN
|
48.4 M | $ 31.33 | -4.03 % | $ 1.44 B | USA |
 |
Orthofix Medical
OFIX
|
157 M | $ 11.58 | -1.61 % | $ 459 M |  Curacao |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
20.7 M | $ 329.2 | -0.2 % | $ 12.8 B | USA |
 |
Insulet Corporation
PODD
|
931 M | $ 203.09 | -0.2 % | $ 14.3 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
2.84 M | $ 2.49 | -1.58 % | $ 6.91 M | USA |
 |
Butterfly Network
BFLY
|
20.4 M | $ 4.03 | -2.42 % | $ 853 M | USA |
 |
Smith & Nephew plc
SNN
|
3.2 B | $ 31.88 | -2.3 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
14.9 B | $ 331.18 | -0.34 % | $ 127 B | USA |
 |
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.59 | 0.69 % | $ 36.7 M | USA |
 |
Tactile Systems Technology
TCMD
|
16 M | $ 24.49 | -0.33 % | $ 560 M | USA |
 |
TELA Bio
TELA
|
55.7 M | $ 0.62 | -2.08 % | $ 29.1 M | USA |
 |
TransMedics Group
TMDX
|
453 M | $ 104.84 | 0.04 % | $ 3.56 B | USA |
 |
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
310 M | $ 19.55 | 1.98 % | $ 1.33 B | USA |
 |
Delcath Systems
DCTH
|
835 K | $ 9.61 | -0.98 % | $ 344 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.1 B | $ 61.27 | -2.11 % | $ 90.7 B | USA |